Report an error

Spotted something inaccurate in “GLP-1 Agonists Linked to Lower AUD Relapse Rates Than Standard Meds in Retrospective Stanford Study of Metabolic Patients”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.